SRI KRISHNA PHARMACEUTICALS LTD
SRI KRISHNA PHARMACEUTICALS LTD (India) holds 12 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 12 active ingredients and is linked to 3 FDA-registered manufacturing sites. 17 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “SRI KRISHNA PHARMACEUTICALS LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sri-krishna-pharmaceuticals-ltd
Overview
SRI KRISHNA PHARMACEUTICALS LTD is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering ACETAMINOPHEN USP; BUTORPHANOL TARTRATE USP; DIMETHYL FUMARATE USP; DOMPERIDONE PH EUR; ENALAPRIL MALEATE USP PROCESS-II; FOLIC ACID USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which SRI KRISHNA PHARMACEUTICALS LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
SRI KRISHNA PHARMACEUTICALS LTD holds 12 active (15 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- TOLVAPTANActive2026-04-14
- ENALAPRIL MALEATE USP PROCESS-IIActive2024-07-16
- DIMETHYL FUMARATE USPActive2024-05-29
- GLYBURIDE USPActive2013-04-19
- GLIPIZIDE USPActive2012-05-07
- BUTORPHANOL TARTRATE USPActive2012-01-17
- DOMPERIDONE PH EURActive2010-12-13
- FUROSEMIDE USPActive2009-12-22
- MECLIZINE HYDROCHLORIDE USPActive2009-12-15
- SODIUM PHENYLBUTYRATE USPActive2006-06-30
- FOLIC ACID USPActive2004-08-16
- ACETAMINOPHEN USPActive2002-02-06
- SODIUM PHENYLBUTYRATE GRANULES 100% (KRISOSPB-100)Inactive2010-10-25
- ACETAMINOPHEN GRANULES DC 90%Inactive2004-08-16
- ACETAMINOPHEN GRANULES DC 90% (KRISOPAP 90F)Inactive2004-05-27
Registered manufacturing sites (3)
Physical sites registered with the US FDA and resolved to SRI KRISHNA PHARMACEUTICALS LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
17 FDA enforcement records linked to this company.
- 4832025-06-27
Investigations of discrepancies, failures
- 4832025-06-27
Rejecting When Specifications Not Met
- 4832025-06-27
Extent of discrepancy, failure investigations
- 4832025-06-27
Drug products - samples representative, identified properly
- 4832025-06-27
Absence of Written Procedures
- 4832025-06-27
Records not made readily available to FDA
- 4832025-06-27
Complaint Investigation/Follow-Up Findings
- 4832025-06-27
Cleaning / Sanitizing / Maintenance
- 4832023-05-19
Computer control of master formula records
- 4832023-05-19
Buildings not maintained in good state of repair
- 4832023-05-19
Cleaning / Sanitizing / Maintenance
- 4832023-05-19
Master production and control records, procedure
- 4832023-05-19
Investigations of discrepancies, failures
- 4832023-05-19
Absence of Written Procedures
- 4832023-05-19
Procedures not in writing, fully followed
- 4832023-05-19
Complaint Handling Procedure
- warning_letter2016-04-01
FDA Warning Letter (drug product)
Is this SRI KRISHNA PHARMACEUTICALS LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.